°Ë»ö°á°ú: ÃÑ 30°³ Áß 21 - 34 |
¸íÀÎÆä´ÏÅäÀÎÁ¤100mg(Æä´ÏÅäÀÎ)ÀÇ º´¿ë±Ý±â¿¡ ÇØ´çµÇ´Â Á¦Ç°
Á¦Ç°¸í | ¼ººÐ¸í | ÁÖ¼ººÐÄÚµå | Ç¥ÁØÄÚµå¡å | ÆǸŻç | °í½Ã¹øÈ£ | Àû¿ëÀÏ |
¾Ë·»½Ãĸ½¶75¹Ð¸®±×·¥(ÆȺ¸½ÃŬ¸³)_(75mg/1ĸ½¶) | palbociclib | 655201ACH | 641807240 | ±¤µ¿Á¦¾à(ÁÖ) | 20180088 | 20181102 |
ÄÉ·»µð¾ÆÁ¤10¹Ð¸®±×·¥(Çdz׷¹³í)_(10mg/1Á¤) | finerenone | 729201ATB | 641106200 | ¹ÙÀÌ¿¤ÄÚ¸®¾Æ(ÁÖ) | 20240030 | 20240625 |
ÄÉ·»µð¾ÆÁ¤20¹Ð¸®±×·¥(Çdz׷¹³í)_(20mg/1Á¤) | finerenone | 729202ATB | 641106190 | ¹ÙÀÌ¿¤ÄÚ¸®¾Æ(ÁÖ) | 20240030 | 20240625 |
Á¨º¸¾ßÁ¤_(1Á¤) | cobicistat silicon dioxide (as cobicistat) | 655900ATB | 625900090 | ±æ¸®¾îµå»çÀ̾ð½ºÄÚ¸®¾Æ(À¯) | 20190131 | 20191217 |
Á¨º¸¾ßÁ¤_(1Á¤) | elvitegravir | 655900ATB | 625900090 | ±æ¸®¾îµå»çÀ̾ð½ºÄÚ¸®¾Æ(À¯) | 20190131 | 20191217 |
Á¨º¸¾ßÁ¤_(1Á¤) | emtricitabine | 655900ATB | 625900090 | ±æ¸®¾îµå»çÀ̾ð½ºÄÚ¸®¾Æ(À¯) | 20190131 | 20191217 |
Á¨º¸¾ßÁ¤_(1Á¤) | tenofovir alafenamide fumarate (as tenofovir alafenamide) | 655900ATB | 625900090 | ±æ¸®¾îµå»çÀ̾ð½ºÄÚ¸®¾Æ(À¯) | 20190131 | 20191217 |
ÇϺ¸´ÏÁ¤_(1Á¤) | ledipasvir | 645800ATB | 625900060 | ±æ¸®¾îµå»çÀ̾ð½ºÄÚ¸®¾Æ(À¯) | 20170086 | 20171106 |
ÇϺ¸´ÏÁ¤_(1Á¤) | sofosbuvir | 645800ATB | 625900060 | ±æ¸®¾îµå»çÀ̾ð½ºÄÚ¸®¾Æ(À¯) | 20170086 | 20171106 |
¼Ò¹ßµðÁ¤(¼ÒÆ÷½ººÎºñ¸£)_(0.4g/1Á¤) | sofosbuvir | 644401ATB | 625900050 | ±æ¸®¾îµå»çÀ̾ð½ºÄÚ¸®¾Æ(À¯) | 20170086 | 20171106 |
¸¶ºñ·¿Á¤_(1Á¤) | glecaprevir | 669700ATB | 624900290 | Çѱ¹¾Öºêºñ(ÁÖ) | 20200130 | 20201228 |
¸¶ºñ·¿Á¤_(1Á¤) | pibrentasvir | 669700ATB | 624900290 | Çѱ¹¾Öºêºñ(ÁÖ) | 20200130 | 20201228 |
´ÙºñÄĸ½¶150mg(´Ùºñ°¡Æ®¶õ¿¡ÅؽǷ¹ÀÌÆ®¸Þ½Ç»ê¿°)_(0.17295g/1ĸ½¶) | dabigatran etexilate mesylate (as dabigatran etexilate) | 613702ACH | 052400700 | (ÁÖ)ÀÎÆ®·Î¹ÙÀÌ¿ÀÆĸ¶ | 20180088 | 20181102 |
´ÙºñÄĸ½¶110mg(´Ùºñ°¡Æ®¶õ¿¡ÅؽǷ¹ÀÌÆ®¸Þ½Ç»ê¿°)_(0.12683g/1ĸ½¶) | dabigatran etexilate mesylate (as dabigatran etexilate) | 613701ACH | 052400680 | (ÁÖ)ÀÎÆ®·Î¹ÙÀÌ¿ÀÆĸ¶ | 20180088 | 20181102 |